Paul A Ramsland Selected Research

Monoclonal Antibodies

1/2020	The terminal sialic acid of stage-specific embryonic antigen-4 has a crucial role in binding to a cancer-targeting antibody.
10/2015	Structural biology of antibody recognition of carbohydrate epitopes and potential uses for targeted cancer immunotherapies.
10/2015	Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases.
9/2013	Formation of assemblies on cell membranes by secreted proteins: molecular studies of free λ light chain aggregates found on the surface of myeloma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul A Ramsland Research Topics

Disease

17	Neoplasms (Cancer) 01/2020 - 07/2004
6	Infections 05/2018 - 09/2007
4	Carcinoma (Carcinomatosis) 01/2020 - 07/2004
4	Malaria 05/2018 - 01/2013
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2015 - 08/2010
3	Multiple Myeloma 09/2013 - 05/2002
3	Autoimmune Diseases (Autoimmune Disease) 12/2009 - 01/2009
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2019
2	Inflammation (Inflammations) 10/2015 - 09/2011
2	Communicable Diseases (Infectious Diseases) 10/2015 - 01/2015
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2013 - 02/2008
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2009 - 02/2002
1	Alzheimer Disease (Alzheimer's Disease) 08/2021
1	Hypersensitivity (Allergy) 11/2020
1	Hepatitis C 06/2019
1	Vivax Malaria 05/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2015
1	Bacterial Vaginosis 01/2015
1	Disease Susceptibility (Diathesis) 01/2015
1	Dysbiosis 01/2015
1	HIV Infections (HIV Infection) 01/2013
1	Genital Diseases 02/2010
1	Multiple Sclerosis 12/2009
1	Experimental Arthritis 01/2009
1	Arthritis (Polyarthritis) 01/2009
1	Rheumatoid Arthritis 01/2009
1	Amyloidosis 05/2002
1	Amyloid Plaque 05/2002

Drug/Important Bio-Agent (IBA)

10	AntibodiesIBA 01/2020 - 07/2004
10	VaccinesIBA 06/2019 - 11/2006
8	CarbohydratesIBA 01/2020 - 07/2004
5	AntigensIBA 10/2015 - 07/2004
4	Peptides (Polypeptides)IBA 11/2020 - 11/2006
4	Monoclonal AntibodiesIBA 01/2020 - 09/2013
4	Blood Group Antigens (Blood Groups)IBA 01/2020 - 07/2004
3	Polysaccharides (Glycans)IBA 01/2020 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2015 - 02/2002
2	Immunoglobulin G (IgG)IBA 01/2020 - 10/2015
2	GlycolipidsIBA 01/2020 - 01/2017
2	Biological ProductsIBA 01/2017 - 10/2015
2	Glycoproteins (Glycoprotein)IBA 01/2017 - 01/2013
2	EpitopesIBA 01/2017 - 10/2015
2	OligosaccharidesIBA 01/2015 - 12/2005
2	MDX-1097IBA 09/2013 - 05/2011
2	Immunoglobulin M (IgM)IBA 01/2013 - 02/2008
2	Antigen-Antibody Complex (Immune Complex)IBA 09/2011 - 01/2009
2	Local Anti-Infective Agents (Antiseptics)IBA 06/2011 - 08/2010
1	baicaleinIBA 08/2021
1	Chalcone (Benzalacetophenone)IBA 08/2021
1	Amyloid beta-PeptidesIBA 08/2021
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2020
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2020
1	stage-specific embryonic antigen-4IBA 01/2020
1	Melitten (Melittin)IBA 01/2019
1	Bee Venoms (Bee Venom)IBA 01/2019
1	LectinsIBA 01/2018
1	PhosphatidylserinesIBA 01/2017
1	Malaria VaccinesIBA 10/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	ProteomeIBA 01/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2015
1	Volatile Fatty AcidsIBA 01/2015
1	CryoglobulinsIBA 01/2013
1	GangliosidesIBA 01/2012
1	astodrimerIBA 06/2011
1	LigandsIBA 12/2009
1	Fc gamma receptor IIAIBA 01/2009
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2009
1	Fc Receptors (Fc Receptor)IBA 01/2009
1	Immunoglobulin A (IgA)IBA 09/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2006
1	Lewis Blood Group AntigensIBA 12/2005
1	Bence Jones ProteinIBA 05/2002
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 05/2002
1	AutoantibodiesIBA 02/2002

Therapy/Procedure

10	Immunotherapy 11/2020 - 07/2004
4	Therapeutics 01/2020 - 01/2009
1	Radiotherapy 01/2018
1	Radioimmunotherapy 12/2016
1	Art Therapy 01/2013
1	Organ Transplantation 02/2011
1	Heterologous Transplantation (Xenotransplantation) 12/2009